ICONE-RX: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
ICONE-RX
Largest movements
- Cash -€17,429
down €17,429 (-31.5%), from €55,398 to €37,969
mainly Investment in fixed assets (net) (-€11,737) and Net result for the year (-€8,316)
- Tangible fixed assets +€7,849
up €7,849 (+2.3%), from €335,893 to €343,742
of which Plant, machinery and equipment: +€7,849
- Profit (loss) carried forward -€8,316
down €8,316 (-354.1%), from -€2,348 to -€10,664
- Depreciation +€2,793
up €2,793 (+160.6%), from €1,739 to €4,533
- Purchases and services +€1,920
new in 2025: €1,920
- Gross operating margin -€1,726
down €1,726 (-891.2%), from -€194 to -€1,920
- Other operating charges +€1,445
up €1,445 (+375.8%), from €384 to €1,829
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €391,936 | €381,711 | -€10,225 | -2.6% |
| Formation expenses | 20 | €645 | - | -€645 | |
| Fixed assets | 21/28 | €335,893 | €343,742 | +€7,849 | +2.3% |
| Tangible fixed assets | 22/27 | €335,893 | €343,742 | +€7,849 | +2.3% |
| Land and buildings | 22 | €306,807 | €306,807 | = | 0.0% |
| Plant, machinery and equipment | 23 | €29,086 | €36,935 | +€7,849 | +27.0% |
| Current assets | 29/58 | €55,398 | €37,969 | -€17,429 | -31.5% |
| Cash at bank and in hand | 54/58 | €55,398 | €37,969 | -€17,429 | -31.5% |
| Total equity and liabilities | 10/49 | €391,936 | €381,711 | -€10,225 | -2.6% |
| Equity | 10/15 | €12,652 | €4,336 | -€8,316 | -65.7% |
| Contributions | 10/11 | €15,000 | €15,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€2,348 | -€10,664 | -€8,316 | -354.1% |
| Amounts payable | 17/49 | €379,284 | €377,375 | -€1,909 | -0.5% |
| Amounts payable within one year | 42/48 | €379,284 | €377,375 | -€1,909 | -0.5% |
| Trade debts | 44 | €1,909 | - | -€1,909 | |
| Suppliers | 440/4 | €1,909 | - | -€1,909 | |
| Other amounts payable | 47/48 | €377,375 | €377,375 | = | 0.0% |
| Goods, raw materials, services and sundry goods | 60/61 | - | €1,920 | +€1,920 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €1,739 | €4,533 | +€2,793 | +160.6% |
| Other operating charges | 640/8 | €384 | €1,829 | +€1,445 | +375.8% |
| Gross operating margin | 9900 | -€194 | -€1,920 | -€1,726 | -891.2% |
| Operating profit (loss) | 9901 | -€2,318 | -€8,282 | -€5,964 | -257.4% |
| Financial charges | 65/66B | €31 | €34 | +€3 | +9.6% |
| Recurring financial charges | 65 | €31 | €34 | +€3 | +9.6% |
| Profit (loss) for the period before taxes | 9903 | -€2,348 | -€8,316 | -€5,967 | -254.1% |
| Profit (loss) for the period | 9904 | -€2,348 | -€8,316 | -€5,967 | -254.1% |
| Profit (loss) for the period to be appropriated | 9905 | -€2,348 | -€8,316 | -€5,967 | -254.1% |
Source: filed annual accounts (NBB), fiscal years ended 1 March 2024 and 31 March 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 1 October 2026 via checked.be.